Abstract

Every living cell is covered with a dense and complex layer of glycans on the cell surface, which have important functions in the interaction between cells and their environment. Glycosphingolipids (GSLs) are glycans linked to lipid molecules that together with sphingolipids, sterols, and proteins form plasma membrane lipid rafts that contribute to membrane integrity and provide specific recognition sites. GSLs are subdivided into three major series (globo-, ganglio-, and neolacto-series) and are synthesized in a non-template driven process by enzymes localized in the ER and Golgi apparatus. Altered glycosylation of lipids are known to be involved in tumor development and metastasis. Metastasis is frequently linked with reversible epithelial-to-mesenchymal transition (EMT), a process involved in tumor progression, and the formation of new distant metastatic sites (mesenchymal-to-epithelial transition or MET). On a single cell basis, cancer cells lose their epithelial features to gain mesenchymal characteristics via mechanisms influenced by the composition of the GSLs on the cell surface. Here, we summarize the literature on GSLs in the context of reversible and cancer-associated EMT and discuss how the modification of GSLs at the cell surface may promote this process.

Highlights

  • Epithelial-to-mesenchymal transition (EMT) is a highly dynamic and reversible process where epithelial cells gradually convert into mesenchymal cells

  • Gb3 [54,55,56]; we have previously demonstrated that the depletion of globosides in ovarian cancer cells using CRISPR-Cas9 resulted in a loss of epithelial markers and induced an epithelial-to-mesenchymal transition (EMT)

  • The anthracycline antibiotic substance doxorubicin elicits cytotoxic effects by intercalating into DNA and has been described in the context of acquired drug resistance as part of EMT [30,61]. These studies demonstrated that the globoside Gb3 on the cell surface of primarily epithelial cancer cells are involved in EMT and that either enzymatic inhibition or gene deletion of

Read more

Summary

Introduction

Epithelial-to-mesenchymal transition (EMT) is a highly dynamic and reversible process where epithelial cells gradually convert into mesenchymal cells. EMT is not a dual process, but a network of multiple states [6] where tumor cells alter their epithelial and mesenchymal markers, allowing them to display an array of migratory behaviors [7] The cholera toxin treatment induced the activation of the protein kinase A signaling pathway, triggering mesenchymal cancer stem cells to gain epithelial stem-like properties. The emerging role of GSLs in epithelial-to-mesenchymal transition (EMT) was previously mentioned as a process that enables metastatic cellular invasion in the context of cancer progression, highlighting the spontaneous and transforming growth factor β (TGFβ)-induced alterations of GSLs [32]. The review summarizes the literature on GSLs in the context of EMT/MET with a specific focus on cancer and discusses how the modification of GSLs may trigger this transition

Human Glycosphingolipids Biosynthesis
Globo-Series GSLs
Gb3 and Gb4
Ganglio-Series GSLs
Monosialylated Gangliosides
Disialylated Gangliosides
An Overview of Current Methodologies to Characterize GSLs
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call